Aspirin 325mg Tablet Franchise in Ahmedabad

Antiplatelet & Analgesic Tablet Supplier in Bangalore

Aspirin 325mg Medicine Distributor in Hyderabad

Pain Relief & Heart Health Tablet Franchise in Jaipur

Cardiovascular & Analgesic Tablet Stockist in Mumbai
Aspirin Tablet Export & Manufacturing in Chandigarh

Home/Products /aspirin-325mg-tablet

Asprole 325 Tablet

Composition : Aspirin (325mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Aspofoli 325 Tablet contains Aspirin 325mg, a potent antiplatelet and analgesic formulation. It helps prevent clot formation in blood vessels, lowering the risk of heart attack and stroke, while also providing effective relief from pain, inflammation, and fever. Its dual-action makes it a versatile and essential medicine for long-term cardiovascular care and acute symptom management.

The 325mg strength is commonly used for patients needing stronger antiplatelet therapy or enhanced pain relief. Doctors frequently recommend this dosage for post-surgical care, chronic cardiovascular support, and musculoskeletal or headache-related discomfort. Its consistent efficacy ensures better patient outcomes and high clinical trust.

For distributors and suppliers, Aspofoli 325 Tablet is a high-demand, fast-moving product. Its dual benefits lead to frequent prescriptions, continuous stock replenishment, and sustained sales across pharmacies, hospitals, and clinics. Seasonal cardiovascular care and pain management needs further drive repeat orders, ensuring reliable business growth.

Including Aspofoli 325 Tablet in your product range strengthens your cardiovascular and analgesic portfolio and offers opportunities for bulk supply, institutional sales, export, and third-party manufacturing partnerships. Its clinical significance, constant demand, and multi-purpose application make it a profitable and strategic choice for any pharma distributor or stockist.

Read More

About the Product

Aspofoli 325 Tablet contains Aspirin 325mg, a potent antiplatelet and analgesic formulation. It helps prevent clot formation in blood vessels, lowering the risk of heart attack and stroke, while also providing effective relief from pain, inflammation, and fever. Its dual-action makes it a versatile and essential medicine for long-term cardiovascular care and acute symptom management.

The 325mg strength is commonly used for patients needing stronger antiplatelet therapy or enhanced pain relief. Doctors frequently recommend this dosage for post-surgical care, chronic cardiovascular support, and musculoskeletal or headache-related discomfort. Its consistent efficacy ensures better patient outcomes and high clinical trust.

For distributors and suppliers, Aspofoli 325 Tablet is a high-demand, fast-moving product. Its dual benefits lead to frequent prescriptions, continuous stock replenishment, and sustained sales across pharmacies, hospitals, and clinics. Seasonal cardiovascular care and pain management needs further drive repeat orders, ensuring reliable business growth.

Including Aspofoli 325 Tablet in your product range strengthens your cardiovascular and analgesic portfolio and offers opportunities for bulk supply, institutional sales, export, and third-party manufacturing partnerships. Its clinical significance, constant demand, and multi-purpose application make it a profitable and strategic choice for any pharma distributor or stockist.

Some patients may experience stomach discomfort, acidity, nausea, mild bleeding tendencies such as gum or nosebleeds. Rarely, severe gastrointestinal bleeding, allergic reactions, or tinnitus may occur.

It is indicated for the prevention of heart attack, stroke, and transient ischemic attacks (TIAs), and for the management of mild to moderate pain, inflammation, or fever. It is particularly useful for patients with coronary artery disease or those with increased cardiovascular risk.

Use only under medical supervision. Avoid in patients with active ulcers, bleeding disorders, aspirin allergy, or severe liver/kidney disease. Do not take with other blood thinners without medical advice. Not recommended for children due to the risk of Reye’s syndrome.

Store in a cool, dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation